Clinical Trial Management and Regulatory Support
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
This contract involves providing comprehensive support for the clinical development of Medical Countermeasure (MCM) candidates. The scope of work includes designing clinical trial protocols, preparing and submitting regulatory documents such as Investigational New Drug (IND) and Investigational Device Exemption (IDE) applications, facilitating engagement with the FDA, and overseeing clinical trial sites. The Department of Defense, through its W6QK Acc-Apg office, will have government review rights to ensure compliance and proper execution. The contract is categorized as a subcontract under the NAICS code 541612 and is set to be performed in Frederick. The solicitation was posted on June 3, 2026, with a response deadline of June 22, 2026. Its primary focus is on clinical trial management and regulatory support aimed at advancing MCM candidates through critical development phases, ensuring adherence to regulatory requirements, and maintaining effective communication with federal oversight bodies.
General Info
Agency
NAICS
Place of Performance
Frederick, MD, USASet-Aside
Documents
(0)AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
Response Deadline
